Guided by patient needs, we strive to develop major therapeutic innovations in areas where needs are greatest. These include digestive cancers (stomach cancer, pancreatic cancer, and cholangiocarcinoma, a rare and aggressive form of bile duct cancer), glioma, or brain tumors, hematologic cancers (acute myeloid leukemia, acute lymphoblastic leukemia and lymphoma), and pediatric cancers.
